Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2716524 | The American Journal of Medicine | 2012 | 6 Pages |
Abstract
Adverse events related to intravenous contrast occur in sickle cell disease patients at a rate similar to the general population, without an increase in contrast-induced nephropathy. Subjective reports of new or worsening pain crisis do not translate to objective findings. Beneficial diagnostic imaging can be performed without increased risk of serious complication in this population.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kimberly L. MD, Laryssa M. MD, Suzanne RN, MPH, Jocelyn MSPH, Samir K. MD, Arthur M. MD, PhD, David MD, JD,